Cargando…

Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platform

Reverse genetic systems enable the engineering of RNA virus genomes and are instrumental in studying RNA virus biology. With the recent outbreak of the COVID-19 pandemic, already established methods were challenged by the large genome of SARS-CoV-2. Herein we present an elaborated strategy for the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Kipfer, Enja, Hauser, David, Lett, Martin J., Otte, Fabian, Urda, Lorena, Zhang, Yuepeng, Lang, Christopher M. R., Chami, Mohamed, Mittelholzer, Christian, Klimkait, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245781/
https://www.ncbi.nlm.nih.gov/pubmed/37292682
http://dx.doi.org/10.1101/2023.05.11.540343
_version_ 1785054924087754752
author Kipfer, Enja
Hauser, David
Lett, Martin J.
Otte, Fabian
Urda, Lorena
Zhang, Yuepeng
Lang, Christopher M. R.
Chami, Mohamed
Mittelholzer, Christian
Klimkait, Thomas
author_facet Kipfer, Enja
Hauser, David
Lett, Martin J.
Otte, Fabian
Urda, Lorena
Zhang, Yuepeng
Lang, Christopher M. R.
Chami, Mohamed
Mittelholzer, Christian
Klimkait, Thomas
author_sort Kipfer, Enja
collection PubMed
description Reverse genetic systems enable the engineering of RNA virus genomes and are instrumental in studying RNA virus biology. With the recent outbreak of the COVID-19 pandemic, already established methods were challenged by the large genome of SARS-CoV-2. Herein we present an elaborated strategy for the rapid and straightforward rescue of recombinant plus-stranded RNA viruses with high sequence fidelity, using the example of SARS-CoV-2. The strategy called CLEVER (CLoning-free and Exchangeable system for Virus Engineering and Rescue) is based on the intracellular recombination of transfected overlapping DNA fragments allowing the direct mutagenesis within the initial PCR-amplification step. Furthermore, by introducing a linker fragment – harboring all heterologous sequences – viral RNA can directly serve as a template for manipulating and rescuing recombinant mutant virus, without any cloning step. Overall, this strategy will facilitate recombinant SARS-CoV-2 rescue and accelerate its manipulation. Using our protocol, newly emerging variants can quickly be engineered to further elucidate their biology. To demonstrate its potential as a reverse genetics platform for plus-stranded RNA viruses, the protocol has been successfully applied for the cloning-free rescue of recombinant Chikungunya and Dengue virus.
format Online
Article
Text
id pubmed-10245781
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-102457812023-06-08 Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platform Kipfer, Enja Hauser, David Lett, Martin J. Otte, Fabian Urda, Lorena Zhang, Yuepeng Lang, Christopher M. R. Chami, Mohamed Mittelholzer, Christian Klimkait, Thomas bioRxiv Article Reverse genetic systems enable the engineering of RNA virus genomes and are instrumental in studying RNA virus biology. With the recent outbreak of the COVID-19 pandemic, already established methods were challenged by the large genome of SARS-CoV-2. Herein we present an elaborated strategy for the rapid and straightforward rescue of recombinant plus-stranded RNA viruses with high sequence fidelity, using the example of SARS-CoV-2. The strategy called CLEVER (CLoning-free and Exchangeable system for Virus Engineering and Rescue) is based on the intracellular recombination of transfected overlapping DNA fragments allowing the direct mutagenesis within the initial PCR-amplification step. Furthermore, by introducing a linker fragment – harboring all heterologous sequences – viral RNA can directly serve as a template for manipulating and rescuing recombinant mutant virus, without any cloning step. Overall, this strategy will facilitate recombinant SARS-CoV-2 rescue and accelerate its manipulation. Using our protocol, newly emerging variants can quickly be engineered to further elucidate their biology. To demonstrate its potential as a reverse genetics platform for plus-stranded RNA viruses, the protocol has been successfully applied for the cloning-free rescue of recombinant Chikungunya and Dengue virus. Cold Spring Harbor Laboratory 2023-09-11 /pmc/articles/PMC10245781/ /pubmed/37292682 http://dx.doi.org/10.1101/2023.05.11.540343 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.
spellingShingle Article
Kipfer, Enja
Hauser, David
Lett, Martin J.
Otte, Fabian
Urda, Lorena
Zhang, Yuepeng
Lang, Christopher M. R.
Chami, Mohamed
Mittelholzer, Christian
Klimkait, Thomas
Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platform
title Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platform
title_full Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platform
title_fullStr Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platform
title_full_unstemmed Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platform
title_short Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platform
title_sort rapid cloning-free mutagenesis of new sars-cov-2 variants using a novel reverse genetics platform
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245781/
https://www.ncbi.nlm.nih.gov/pubmed/37292682
http://dx.doi.org/10.1101/2023.05.11.540343
work_keys_str_mv AT kipferenja rapidcloningfreemutagenesisofnewsarscov2variantsusinganovelreversegeneticsplatform
AT hauserdavid rapidcloningfreemutagenesisofnewsarscov2variantsusinganovelreversegeneticsplatform
AT lettmartinj rapidcloningfreemutagenesisofnewsarscov2variantsusinganovelreversegeneticsplatform
AT ottefabian rapidcloningfreemutagenesisofnewsarscov2variantsusinganovelreversegeneticsplatform
AT urdalorena rapidcloningfreemutagenesisofnewsarscov2variantsusinganovelreversegeneticsplatform
AT zhangyuepeng rapidcloningfreemutagenesisofnewsarscov2variantsusinganovelreversegeneticsplatform
AT langchristophermr rapidcloningfreemutagenesisofnewsarscov2variantsusinganovelreversegeneticsplatform
AT chamimohamed rapidcloningfreemutagenesisofnewsarscov2variantsusinganovelreversegeneticsplatform
AT mittelholzerchristian rapidcloningfreemutagenesisofnewsarscov2variantsusinganovelreversegeneticsplatform
AT klimkaitthomas rapidcloningfreemutagenesisofnewsarscov2variantsusinganovelreversegeneticsplatform